Reversal of Type 2 diabetes after bariatric surgery is determined by the degree of achieved weight loss in both short- and long-duration diabetes

Diabetic Medicine

Volumn 32, Issue 1, 2016, Pages 47-53

  Steven, S ^a   Carey, P E ^b   Small, P K ^b   Taylor, R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; SULFONYLUREA; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; BARIATRIC SURGERY; BLOOD GLUCOSE MONITORING; COHORT ANALYSIS; CONTROLLED STUDY; DIET THERAPY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; WEIGHT REDUCTION; BLOOD; BODY MASS; DIABETES MELLITUS, TYPE 2; FOLLOW UP; METABOLISM; MIDDLE AGED; OBESITY, MORBID; PATHOPHYSIOLOGY; PATIENT SELECTION; PROSPECTIVE STUDY; REMISSION; RISK FACTOR; TIME; TREATMENT OUTCOME;

ADULT; BARIATRIC SURGERY; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PATIENT SELECTION; PROSPECTIVE STUDIES; REMISSION INDUCTION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84916932621     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12567     Document Type: Article

References (30)

1. Tabák A, Jokela M, Akbaraly T, Brunner E, Kivimäki M, Witte D. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009; 373: 2215-2221.
2. Martin BC, Warram JH, Krolewski AS, Soeldner JS, Kahn CR, Bergman RN. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992; 340: 925-929.
3. UKPDS. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1999; 352: 837-853.
4. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
5. Anderson J, Kendall C, Jenkins D. Importance of weight management in type 2 diabetes: review with meta-analysis of clinical studies. J Am Coll Nutr 2003; 22: 331-339.
6. Butler A, Janson J, Bonner-Weir S, Ritzel R, Rizza R, Butler P. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003; 52: 102-110.
7. Boucher A, Lu D, Burgess SC, Telemaque-Potts S, Jensen MV, Mulder H et al. Biochemical mechanism of lipid-induced impairment of glucose-stimulated insulin secretion and reversal with a malate analogue. J Biol Chem 2004; 279: 27263-27271.
8. Butler A, Cao-Minh L, Galasso R, Rizza R, Corradin A, Cobelli C et al. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia 2010; 53: 2167-2176.
9. Camastra S, Manco M, Mari A, Greco AV, Frascerra S, Mingrone G et al. Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery. Diabetes Care 2007; 30: 1002-1004.
10. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes is associated with decrease in pancreas and liver fat. Diabetologia 2011; 54: 2506-2514.
11. Schauer P, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-484.
12. Hall TC, Pellen MGC, Sedman PC, Jain PK. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 2010; 20: 1245-1250.
13. Dixon JB, Chuang L-M, Chong K, Chen S-C, Lambert GW, Straznicky NE et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes Care 2013; 36: 20-26.
14. Hayes M, Hunt L, Foo J, Tychinskaya Y, Stubbs R. A model for predicting the resolution of type 2 diabetes in severely obese subjects following Roux-en Y gastric bypass surgery. Obes Surg 2011; 21: 910-916.
15. Dixon J, Zimmet P, Alberti K, Rubino F. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med 2011; 28: 628-642.
16. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L et al. Bariatric Surgery versus Conventional Medical Therapy for Type 2 Diabetes. New Engl J Med 2012; 366: 1577-1585.
17. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. New Engl J Med 2012; 366: 1567-1576.
18. Buse J, Caprio S, Cefalu W, Ceriello A, Del Prato S, Inzucchi S et al. How do we define cure of diabetes? Diabetes Care 2009; 32: 2133-2135.
19. Cohen RV, Pinheiro JC, Schiavon CA, Salles JE, Wajchenberg BL, Cummings DE. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012; 35: 1420-1428.
20. Knop F, Taylor R. Mechanism of metabolic advantages after bariatric surgery: it's all gastrointestinal factors versus it's all food restriction. Diabetes Care 2013; 36(Suppl. 2): S287-291.
21. Taylor R. Pathogenesis of Type 2 diabetes: Tracing the reverse route from cure to cause. Diabetologia 2008; 51: 1781-1789.
22. Lingvay I, Guth E, Islam A, Livingston E. Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care 2013; 36: 2741-2747.
23. Isbell J, Tamboli R, Hansen E, Saliba J, Dunn J, Phillips S et al. The importance of caloric restriction in the early improvement in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care 2010; 33: 1438-1442.
24. Guidone C, Manco M, Valera-Mora E, Iaconelli A, Gniuli D, Mari A et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006; 55: 2025-2031.
25. Taylor R. Type 2 Diabetes: etiology and reversibility. Diabetes Care 2013; 36: 1047-1055.
26. Steven S, Woodcock S, Small P, Taylor R. Type 2 diabetes, bariatric surgery and the risk of subsequent gestational diabetes. Obstet Med 2011; 4: 171-173.
27. Zangeneh F, Arora P, Dyck P, Bekris L, Lernmark A, Achenbach S et al. Effects of duration of type 2 diabetes on insulin secretion. Endocr Pract 2006; 12: 388-393.
28. Jain R, Kabadi U, Kabadi M. Is beta-cell failure in type 2 diabetes mellitus reversible? Int J Diabetes Dev Ctries 2008; 28: 1-5.
29. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-853.
30. Saisho Y, Tanaka K, Abe T, Shimada A, Kawai T, Itoh H. Effect of obesity on declining beta-cell function after diagnosis in type 2 diabetes: a possible link suggested by cross-sectional analysis. Endocr J 2012; 59: 187-195.